Literature DB >> 33586411

Active Giant Cell Vasculitis Diagnosis with 68Ga PSMA PET/CT Imaging.

Muhammet Sait Sağer1, Seçkin Bilgiç1, Lebriz Uslu1, Sertaç Asa1, Güneş Sağer2, Kerim Sönmezoğlu1.   

Abstract

Vasculitis is a multisystem disease characterized by inflammation with infiltration of leukocytes into the blood vessels. Giant cell arteritis (GCA) is the most common form of vasculitis that mostly affects medium- and large-sized arteries. 18Fluorine-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) is increasingly used to diagnose inflammation of large arteries in GCA. Galium-68 prostate-specific membrane antigen (PSMA) PET/CT has a vital role in the assessment of patients with prostate cancer for recurrence and metastasis of the disease. Various benign and non-prostate malignant conditions may give rise to increased PSMA uptake. Herein, we demonstrate that PSMA uptake can be seen in GCA.

Entities:  

Keywords:  18F-FDG PET; GCA; PSMA PET; Vasculitis

Year:  2021        PMID: 33586411      PMCID: PMC7885283          DOI: 10.4274/mirt.galenos.2019.90532

Source DB:  PubMed          Journal:  Mol Imaging Radionucl Ther        ISSN: 2146-1414


  5 in total

Review 1.  Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with large-vessel vasculitis: a systematic review.

Authors:  Giorgio Treglia; Maria Vittoria Mattoli; Lucia Leccisotti; Gianfranco Ferraccioli; Alessandro Giordano
Journal:  Clin Rheumatol       Date:  2011-08-11       Impact factor: 2.980

2.  68Ga-Labeled PSMA Uptake in Nonprostatic Malignancies: Has the Time Come to Remove "PS" From PSMA?

Authors:  Dharmender Malik; Rajender Kumar; Bhagwant Rai Mittal; Harmandeep Singh; Anish Bhattacharya; Shrawan Kumar Singh
Journal:  Clin Nucl Med       Date:  2018-07       Impact factor: 7.794

Review 3.  PET/CT With 68Ga-PSMA in Prostate Cancer: Radiopharmaceutical Background and Clinical Implications.

Authors:  Giampiero Giovacchini; Elisabetta Giovannini; Mattia Riondato; Andrea Ciarmiello
Journal:  Curr Radiopharm       Date:  2018

4.  Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography.

Authors:  A Reum Chun; Hye Min Jo; Seoung Ho Lee; Hong Woo Chun; Jung Mi Park; Kyu Jin Kim; Chan Hee Jung; Ji Oh Mok; Sung Koo Kang; Chul Hee Kim; Bo Yeon Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2014-07-18

Review 5.  The role of 18F-FDG PET/CT in large-vessel vasculitis: appropriateness of current classification criteria?

Authors:  H Balink; R J Bennink; B L F van Eck-Smit; H J Verberne
Journal:  Biomed Res Int       Date:  2014-08-14       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.